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Substance Misuse in Depression and Bipolar Disorder: A Review of Psychological 
Interventions and Considerations for Clinical Practice. 
 
Abstract 
Research has documented high levels of co-morbidity between mental illness and substance 
misuse. This essay explores clinical practice issues relating to ‘dual diagnosis’ substance 
misuse in bipolar disorder and depression. Such misuse is common in this population, and 
presents a number of challenges to clinicians. Those with substance misuse have more severe 
symptoms and an increased risk of relapse. Assessment is complicated by factors such as a 
lack of standardised measures specifically for use with dual diagnosis clients. The 
effectiveness of specific psychological interventions for this population is somewhat unclear, 
though integrated interventions where both problems are treated together are often used. CBT 
has been used with depression and substance use though its effectiveness with bipolar is 
unclear, and motivational interviewing is often used as a supplement to this. Integrated group 
interventions are being developed and appear to be superior to groups focusing on substance 
use alone. Other therapeutic such as Acceptance and Commitment therapy are starting to be 
developed for use with dual diagnosis clients. A number of variables predict outcome from 
interventions, and there may be considerable gender differences which need to be taken into 
account. At present integrated dual diagnosis services are developing slowly within the 
National Health Service though there have been some notable service innovations in recent 
years. It is concluded that those with substance misuse in addition to bipolar disorder or 
depression need to be given special clinical consideration, though more research on how this 
can be effectively done is needed. 
Keywords: Bipolar Disorder, Depression, Substance Misuse, Drug Misuse, Psychological 
Interventions. 
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Introduction 
In recent years there has been an increasing recognition that those with mental illness are at 
increased risk of having ‘co-morbid’ drug and alcohol problems, known collectively as 
‘substance misuse’. ‘Dual diagnosis’ is often used to refer to those with mental illness and 
substance misuse. Those with substance misuse may experience problems in functioning, put 
themselves in danger from their misuse and continue to use despite these negative problems 
(American Psychiatric Association, 2000). Those with ‘dependence’ develop tolerance and 
experience withdrawal symptoms, and have previously unsuccessfully tried to reduce their 
use (APA, 2000). 
 
Those with dual diagnosis present a number of challenges to mental health professionals. 
This essay will discuss clinical practice issues relating substance misuse in bipolar disorder 
and depression. Depression is characterised by feelings of sadness, reduced interest in usual 
activities, sleep disturbances and loss of energy (APA, 2000). Those with bipolar disorder 
experience episodes of mania (Bipolar I disorder) or hypomania (Bipolar II disorder), usually 
with episodes of depression (APA, 2000). Hypomania and mania are characterised by 
symptoms such as impulsivity, racing thoughts, elevated mood and reduced need for sleep 
(APA, 2000).  
 
This essay will discuss the challenges of working with clients with bipolar disorder or 
depression and co-morbid substance misuse, by emphasising the differences between those 
with and without substance misuse. The effect of substance misuse on symptoms and the 
complexities of assessment with this population are discussed, and current research on 
psychological interventions will be evaluated. Finally, other clinical considerations such as 
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service issues will be discussed in order to illustrate the complexity of working with this 
population.  
 
Epidemiology of dual diagnosis 
Prevalence of co-morbidity 
Research has shown that people with depression are four times as likely to have alcohol 
problems (Grant & Harford, 1995), and those with bipolar disorder are eleven times more 
likely to have substance misuse disorders than those with no mental health problems (Regier 
et al., 1990). Bipolar disorder has higher levels of co-morbid substance misuse than any other 
Axis 1 mental illness (Regier, et al., 1990). A third have a current problem (Bauer et al., 
2005), and the majority have had problems with drug or alcohol at some point in their lives 
(Bauer, et al., 2005; Levander et al., 2007). Research has also shown relationships between 
substance misuse and symptoms of depression (Van Laar, Van Dorsselaer, Monshouwer, & 
De Graaf, 2007), mania (Henquet, Krabbendam, de Graaf, ten Have, & van Os, 2006) and 
hypomania (Richardson & Garavan, 2011), in the general population. In addition depression 
is present in 25% of those with alcohol dependence (Lyne, O’Donoghue, Clancy, & O’Gara, 
2011), and 43% of those with cocaine misuse (Brown et al., 1998). Thus there are high levels 
of substance misuse in those with depression and bipolar disorder, and high levels of 
depression in those with substance problems, suggesting co-morbidity is common in a range 
of clinical settings. 
 
Theoretical Explanations of Co-Morbidity 
A number of theories attempt to explain the relationship between mental illness and drug and 
alcohol misuse (Mueser, Drake, & Wallach, 1998). Firstly, there are common factors, such as 
low socio-economic status, which increase vulnerability to both mental illness and substance 
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misuse. Secondly, those who are high risk for mental health problems have their initial 
symptoms triggered by substance misuse. Finally, drug and alcohol could be misused in an 
attempt to self-medicate symptoms of mental illness (Mueser, et al., 1998). Strakowski and 
DelBello (2000) review potential explanations for bipolar and substance misuse co-morbidity 
and conclude that all possible explanations seem to play a part. Though it is somewhat 
unclear why there are such high levels of co-morbidity, it is clear that those with substance 
misuse present a number of challenges to clinicians. This essay will now explore such 
challenges by examining the impact of substance misuse on those with depression and bipolar 
disorder. 
 
Impact of Substance Misuse 
Effect on symptom severity and relapse 
Research has demonstrated that those with depression and substance misuse have more 
severe symptoms and have been symptomatic for longer (Howland et al., 2009), with half the 
likelihood of long-term recovery (Mueller et al., 1994), than those with depression only. 
Similarly, those with bipolar disorder and substance misuse have slower and poorer recovery 
from an acute affective episode (Gaudiano, Uebelacker, & Miller, 2008; Goldberg, Garno, 
Leon, Kocsis, & Portera, 1999; Weiss et al., 2005). Substance misuse also leads to an 
increased risk of relapse and rapid cycling (Ostacher et al., 2010), as well as severe mania 
and an increased likelihood of psychosis (van Rossum et al., 2009). This negative impact is 
seen even in those with remitted substance misuse (Gaudiano, et al., 2008). Thus those with 
substance misuse have more severe mood symptoms and an increased risk of relapse, 
suggesting the need for psychological interventions that address substance misuse.    
 
Importance of Self-medication 
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Those with depression and bipolar disorder often misuse substances for self-medication of 
symptoms, and use specific drugs in attempt to alleviate specific symptoms (Blume, 
Schmaling, & Marlatt, 2000; Weiss et al., 2004), or cope with stress (Healey, Peters, 
Kinderman, McCracken, & Morriss, 2009). Importantly such beliefs about substance misuse 
appear to increase the risk of problematic use; Johnson and Gurin (1994) found that the co-
morbidity between depression and alcohol dependence was higher in those who believed 
alcohol would elevate their mood. Similarly drinking to cope in those with depression has 
been found to predict increased alcohol misuse 10 years later (Holahan, Moos, Holahan, 
Cronkite, & Randall, 2003). It has therefore been suggested that unrealistic beliefs about the 
effectiveness of self-medication need to be assessed and tackled in therapy (Blume et al., 
2000).  
 
Other correlates of substance misuse 
Those with bipolar disorder and alcohol dependence have poorer neuropsychological 
functioning (Shan et al., 2011), raising questions for ability to engage in therapy. There is 
also elevated impulsivity (Holmes et al., 2009), suggesting that interventions to tackle this 
may be useful. Substance misuse in bipolar disorder is linked to lower quality of life (Weiss, 
et al., 2005), poorer occupational functioning (Goetz et al., 2007), higher levels of aggression 
(Grunebaum et al., 2006), frequent suicide attempts and earlier symptom onset (Richardson, 
2011). Alcohol misuse elevates suicide risk in those with depression (Yaldizli, Kuhl, Graf, 
Wiesbeck, & Wurst, 2010) and bipolar disorder (Comtois, Russo, Roy-Byrne, & Ries, 2004). 
Those with substance misuse are therefore high risk and may require more intense 
intervention and monitoring. There is also an increased likelihood of having a co-morbid 
anxiety disorder (Richardson, 2011), or personality disorder (Mazza et al., 2009), so 
appropriate psychological interventions for these may be needed. Finally, there appear to be 
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demographic differences; bipolar patients with drug and alcohol problems are younger and 
predominantly male and unmarried (Richardson, 2011). Richardson (2011) suggests that 
these demographic variables may be used to identify those who are high risk for the 
development of substance misuse so that preventative interventions can be employed.  
 
Medication Issues 
Medication is rec mmended by the National Institute of Clinical Excellence (NICE) for 
bipolar disorder (NICE, 2006) and severe or treatment resistant depression (NICE, 2009). 
However, those with co-morbid substance misuse are less compliant with medication regimes 
(van Rossum, et al., 2009), and have a greater risk of complications such as anti-depressant 
induced hypomania (Goldberg & Whiteside, 2002). There are few controlled trials on the 
effectiveness of medications for depression or bipolar disorder with substance misuse (Azorin 
et al., 2010; Torrens, Fonseca, Mateu, & Farré, 2005), and medications for depression and 
substance misuse are more effective when psychosocial interventions are also used (Nunes & 
Levin, 2004). Therefore there is an increased need for psychological interventions with this 
population. This essay will now look at issues relating to diagnosis and assessment in this 
population. 
 
Assessment and Diagnostic Issues 
Primary/Secondary Distinction 
Whilst the term ‘dual diagnosis’ suggests an equal emphasis on the mood disorder and 
substance misuse, diagnostic classification systems rely on defining a primary and secondary 
diagnosis (APA, 2000). However, research has found that the primary/secondary distinction 
does not predict outcomes from treatment (Hasin, Trautman, Miele, & Samet, 1996), and 
whether the mood disorder or substance misuse is dominant changes over time (Crum, 
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Brown, Liang, & Eaton, 2001). Thus it has been suggested that interventions should focus on 
impaired functioning and distress regardless of specific diagnoses or models of aetiology 
(Schuckit et al., 1997). 
 
Challenges in Assessment 
Substance misuse is often missed in those with mental health problems (Weaver et al., 2003). 
Conversely, those using cocaine are frequently incorrectly diagnosed with bipolar disorder on 
the basis of mood instability (Goldberg et al., 2008), which is a feature of both bipolar 
disorder and dependence. There is also overlap between the symptoms of depression and drug 
withdrawal, so separating the symptoms is complex (Myrick & Brady, 2003). Incorrect 
assessments are often made when mood symptoms are assessed before detoxification 
(Goldberg, et al., 2008), so it is important to conduct assessments when patients are stable in 
mood and not under the influence (Whicher & Abou-Saleh, 2007). 
 
Research has shown that both mood symptoms and substance misuse are under-reported in 
the general population (Andrews, Henderson, & Hall, 2001). However, work with dual 
diagnosis populations has shown that discrepancies between self-report and urine tests occur 
less than 5% of the time (Weiss et al., 2007; Weiss et al., 1998). It has been suggested that 
self-report is more accurate when patients are not psychotic, with familiar staff, and where 
honesty about misuse is encouraged (Weiss, et al., 1998). Collateral reports from friends and 
family are often used to assess substance misuse; however research suggests that asking 
families may be of little value compared to self-report (Weiss, Greenfield, Griffin, Najavits, 
& Fucito, 2000).  
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Assessment needs to determine the age of onset of problems in order to determine whether 
mood symptoms or substance misuse came first (Kay-Lambkin, Baker, & Carr, 2007). Due to 
high suicide risk (Comtois, et al., 2004; Yaldizli, et al., 2010) a risk assessment is vital. 
Discussing the frequency and duration of misuse may help identify triggers, and examining 
how substance misuse affects mood is important in developing a formulation (Kay-Lambkin, 
et al., 2007). 
 
Psychometric Tools 
The utility of commonly used psychometric tools with dual diagnosis patients is unclear. 
Tools such as the ‘Chemical Use, Abuse and Dependence scale’ and ‘Dartmouth Assessment 
of Lifestyle Instrument’ have adequate sensitivity and specificity in detecting substance 
misuse in those with mental illness (Appleby, Dyson, Altman, McGovern, & Luchins, 1996; 
Rosenberg et al., 1998). The ‘Psychiatric Research Interview for Substance and Mental 
Disorders’ has been found to be reliable for detecting affective disorders in those with heavy 
drug and alcohol misuse (Hasin, et al., 1996).  
 
The ‘Beck Depression Inventory’ (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) can be 
used to distinguish substance misuse patients with or without depression (Lykke, Hesse, 
Austin, & Oestrich, 2008), though it may have good sensitivity but poor specificity 
(Holtzheimer et al., 2010). A modified version (Beck, Steer, & Brown, 2000) has a reduced 
focus on somatic symptoms, and therefore may have less overlap with substance withdrawal 
and be more appropriate for those with dual diagnosis (Kay-Lambkin, et al., 2007). A 
modified version of the ‘Hamilton Depression Rating Scale’ has good reliability when used 
with those with bipolar disorder and substance misuse (Kolodziej, Griffin, Bender, & Weiss, 
2008). The ‘Centre for Epidemiological Studies Depression Scale’ has limited overlap with 
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substance misuse symptoms and can be used to detect depression, though it may be more 
accurate for those using alcohol than drugs (Eaton, Smith, Ybarra, Carles, & Tien, 2004). The 
‘Substance Abuse Treatment Scale’ can be used to assess treatment progress in those with 
dual diagnosis (McHugo, Drake, Burton, & Ackerson, 1995), and measures of readiness to 
change can be used with dual diagnosis patients (Nidecker, DiClemente, Bennett, & Bellack, 
2008). Thus a number of questionnaires have been developed for use with dual diagnosis 
clients specifically, though for some questionnaires the reliability is unclear at present. This 
essay will now explore the effectiveness of specific psychological interventions for this dual 
diagnosis population.  
 
Psychological Interventions 
Integrated Interventions 
In recent years interventions have changed from treating substance misuse and mental health 
separately to treating them together (Watkins, Hunter, Burnam, Pincus, & Nicholson, 2005). 
Farren and McElroy (2008) have developed such an ‘integrated’ inpatient programme for 
those with bipolar or depression and substance misuse. This includes detoxification and mood 
stabilisation, followed by psychoeducation, individual therapy and group sessions with a 
relapse prevention focus. A case series demonstrated this intervention reduced substance 
misuse and improved affective symptoms (Farren & McElroy, 2008).  
 
Some reviews have concluded that integrated interventions are more effective than separate 
interventions (Drake & Mueser, 2000; Reedy & Hall, 2008). Though those with depression 
and substance misuse can be given addiction treatment alongside those with substance misuse 
alone (Galanter, Egelko, Edwards, & Katz, 1996), those with depression have more severe 
dependence (Burns, Teesson, & O'Neill, 2005; Leventhal, Mooney, DeLaune, & Schmitz, 
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2006), higher levels of drop-out (Brown, et al., 1998) and poorer outcomes from addiction 
treatment (Brown, et al., 1998; Burns, et al., 2005; Curran, Booth, Kirchner, & Deneke, 2007; 
Dodge, Sindelar, & Sinha, 2005). Thus whether those with depression can be treated using 
standard substance dependence interventions is unclear. 
 
Research suggests that integrated interventions for bipolar disorder reduce substance misuse 
but have little impact on affective symptoms (Drake, Xie, McHugo, & Shumway, 2004). Due 
to little research and methodological limitations there is insufficient evidence at present to 
support the effectiveness of integrated interventions over treating substance misuse alone 
(Donald, Dower, & Kavanagh, 2005; Hesse, 2009). Despite this a number of specific 
integrated interventions have been developed. 
 
Cognitive Behaviour Therapy 
Cognitive Behaviour Therapy (CBT) is recommended for bipolar disorder (NICE, 2006) and 
Depression (NICE, 2009). However, many randomised controlled trials exclude those with 
current (Lam, Hayward, Watkins, Wright, & Sham, 2005; Lam et al., 2003), or past (Kessler 
et al., 2009) substance misuse. Recent research has begun to adapt CBT for those with co-
morbid substance misuse, using CBT to address thoughts and behaviours which underlie both 
mood and substance problems. These include elements such as mood, substance misuse and 
craving monitoring, scheduling activities unrelated to drug misuse, working on automatic 
thoughts, problem solving, relapse prevention, and social skills and assertiveness training 
(Baker & Velleman, 2009; Brown, Evans, Miller, Burgess, & Mueller, 1997; Lydecker et al., 
2010). It has been suggested that an important component should be testing beliefs about the 
effectiveness of self-medication (Blume et al., 2000) 
 
Page 11 of 39
URL: http://mc.manuscriptcentral.com/RMHS  Email: editor@mhsu.co.uk
Mental Health and Substance Use
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
12 
 
Research has shown that integrated CBT reduces both substance misuse and depression 
(Lydecker, et al., 2010), more so than focusing on either depression or substance misuse 
(Baker et al., 2010). CBT has also been found to improve depression in those with alcohol 
dependence (Brown, et al., 1997) and amphetamine misuse (Bauer, et al., 2005). A 
computerised CBT intervention has been found to be effective for those with depression and 
alcohol or cannabis problems (Kay-Lambkin, Baker, Lewin, & Carr, 2009). Work suggests 
that improvements in depression are related to reduced substance misuse (Baker et al., 2005), 
and an increased perceived ability to cope with low mood without drinking (Ramsey, Brown, 
Stuart, Burgess, & Miller, 2002). This suggests that work on beliefs about alcohol misuse and 
self-efficacy to control mood should be key components of CBT interventions. Despite 
encouraging results from individual studies, a recent systematic review concluded that the 
efficacy of CBT for depression with substance misuse is relatively unclear at present (Hides, 
Samet, & Lubman, 2010).  
 
There is even less research examining the effectiveness of CBT for bipolar disorder with 
substance misuse. Schmitz et al. (2002) found that CBT improved medication compliance, 
reduced treatment drop-out and moderately improved in affective symptoms. However, 
substance misuse was not reduced (Schmitz et al., 2002). Thus integrative CBT interventions 
have been developed but their evidence base is limited at present.  
 
Motivational Interviewing 
Motivational Interviewing (MI) has been adapted for those with dual diagnosis, with a focus 
on the pros and cons of change, and the relationship between mental health and substance 
misuse (Martino, Carroll, Kostas, Perkins, & Rounsaville, 2002). Such motivational 
techniques have been found to increase appointment attendance in those with dual diagnosis 
Page 12 of 39
URL: http://mc.manuscriptcentral.com/RMHS  Email: editor@mhsu.co.uk
Mental Health and Substance Use
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
13 
 
(Swanson, Pantalon, & Cohen, 1999), and reduce alcohol misuse in psychiatric inpatients 
(Hulse & Tait, 2002). There has been little work applying this specifically to depression or 
bipolar disorder, though a small study without a control group showed that MI for those with 
cocaine dependence and depression increased treatment adherence (Daley, Salloum, Zuckoff, 
Kirisci, & Thase, 1998). MI components have also been used alongside CBT for those with 
mood and substance misuse problems (Baker & Velleman, 2009; Kay-Lambkin, et al., 2009). 
A systematic review concluded that MI is the most effective intervention for reducing 
substance misuse in those with dual diagnosis, and combining this with CBT also improves 
mental health (Cleary, Hunt, Matheson, & Walter, 2009). Thus MI may be useful to reduce 
drop out and improve substance misuse outcomes as part of a wider intervention.  
 
Group Interventions 
Group interventions developed for dual diagnosis can lead to improvements in both substance 
misuse and mental health (James et al., 2004). An integrated CBT group intervention has 
been developed specifically for those with depression and substance misuse (Osilla, Hepner, 
Munoz, Woo, & Watkins, 2009), though its effectiveness has not yet been studied. Weiss, 
Najavits and Greenfield (1999) developed a 20-week relapse prevention group for those with 
bipolar disorder and substance misuse, which aimed to provide education, peer support and 
enhance motivation. An important component of these group interventions is the idea that 
similar thinking and behaviour patterns underlie both mood and drug problems (Weiss, 2004; 
Weiss, et al., 2007). The authors have tried to encourage such an integrative view by asking 
participants to consider themselves as having a diagnosis of ‘bipolar substance misuse’ 
(Weiss, 2004). This integrative focus includes discussing the effect of drug misuse on mood, 
coping with high risk situations and alternative ways to cope with mood symptoms (Weiss, et 
al., 1999).  
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This group intervention has been found to reduce addiction severity and increase the 
likelihood of abstinence (Weiss et al., 2000). Whilst it leads to more pronounced 
improvements than group drug counselling on substance misuse outcomes, there is no 
difference on bipolar severity (Weiss, et al., 2007). A shortened version of this intervention 
has been shown to be superior to group drug counselling in reducing misuse (Weiss et al., 
2009). It also reduced the risk of a depression relapse by 70%, though the impact on mania 
was not as pronounced (Weiss, et al., 2009). This group intervention has been found to lead 
to improvements only in those who use drugs to self-medicate their affective symptoms 
(Weiss, et al., 2004). Thus it has been suggested that such interventions should be targeted at 
those who believe that substance misuse helps their mood (Weiss, et al., 2004). 
 
Other approaches 
A behavioural intervention where those with depression are given vouchers for attendance 
has been found to improve depression but not drug misuse (Carpenter, Aharonovich, Smith, 
Iguchi, & Nunes, 2006). Brief sessions and phone contact with the client and their family 
improve medication adherence in those with bipolar and substance misuse (Gaudiano, 
Weinstock, & Miller, 2011). Acceptance and Commitment Therapy has been adapted for use 
with depression and co-morbid alcohol misuse, though a small study showed improvements 
in depression were not greater than treatment as usual (Petersen & Zettle, 2009). As 
substances are often misused to cope it has been suggested that teaching distress tolerance 
skills may be of use (Blume et al., 2000). This could be done using Dialectical Behaviour 
Therapy, which has shown promise when used with those with borderline personality 
disorder and co-morbid substance misuse (Linehan et al., 1999; van den Bosch, Verheul, 
Schippers, & van den Brink). Mindfulness-Based Cognitive Therapy (MBCT) is 
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recommended for this with treatment resistant depression (NICE, 2009), and has shown 
promise for bipolar disorder (Weber et al., 2010; Williams et al., 2008). A number of authors 
have suggested that MBCT may be useful for depression with substance misuse (Brewer, 
Bowen, Smith, Marlatt, & Potenza, 2010; Kay-Lambkin, et al., 2007). Mindfulness 
components have been included in CBT interventions (Baker, et al., 2010), and an MBCT 
intervention has been developed specifically for those with co-morbid mood disorders and 
substance misuse (Hoppes, 2006). However as of yet there are no trials assessing its 
effectiveness. Thus a number of therapeutic techniques may be helpful but have yet to be 
evaluated in relation to this specific dual diagnosis population. There are a number of 
additional considerations for clinical practice which will now be examined.   
 
Considerations for Clinical Practice 
Detoxification and Abstinence 
Polysubstance misuse is common in those with dual diagnosis (Gual, 2007). Some 
interventions require detoxification prior to therapeutic work (Farren & McElroy, 2008), 
whilst others allow use so long as clients are not under the influence in sessions, and therapy 
is scheduled for times when substance misuse is unlikely (Carroll et al., 2009). It has been 
suggested that demanding abstinence prior to therapy will create a ‘revolving door’ scenario 
and reduce help-seeking, thus the goal of total abstinence may be unrealistic for those with 
dual diagnosis and the focus should be on harm reduction (Blume et al., 2000).  
 
Predictors of outcome 
Outcomes after dual diagnosis are better for those with higher cognitive functioning (Hunt, 
Baker, Michie, & Kavanagh, 2009), suggesting that those with poor functioning should be 
offered more intense treatment and monitored carefully. Outcomes are also improved in those 
Page 15 of 39
URL: http://mc.manuscriptcentral.com/RMHS  Email: editor@mhsu.co.uk
Mental Health and Substance Use
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
16 
 
with higher levels of social support (Warren, Stein, & Grella, 2007), and higher self-efficacy 
(Glasner-Edwards et al., 2007; Warren, et al., 2007). Thus work on social skills, and attempts 
to increased perceived self-efficacy over problems may be effective. Longer time spent in 
treatment and higher attendance also predicts greater improvements (Lydecker, et al., 2010; 
Warren, et al., 2007) so motivational interventions to increase attendance are important. 
 
Outcomes are poorer for those who are younger (Farren & McElroy, 2008; Graff, Griffin, & 
Weiss, 2008), less educated (Graff, et al., 2008), unemployed (Farren & McElroy, 2010) or 
from an ethnic minority group (Carpenter, et al., 2006). Those who have more severe 
affective symptoms (Farren & McElroy, 2008), or a recent mood episode (Graff et al., 2008) 
also have poorer outcomes indicating the importance of a stable mood prior to intervention. 
High levels of anxiety or a co-morbid anxiety disorder (Farren & McElroy, 2010; Howland, 
et al., 2009; Nomarniukor & Brown, 2009), appear to impair outcome so psychological 
interventions to improve anxiety may be efficacious. Those who have more severe substance 
misuse show less benefit from treatment (Graff, et al., 2008; Nomarniukor & Brown, 2009; 
Stein et al., 2004; Warren, et al., 2007), indicating closer monitoring to prevent relapse. A 
measure of craving, the ‘Obsessive Compulsive Drinking Scale’ (Anton, Moak, & Latham, 
1996) has been found to predict relapse in those with depression or bipolar disorder and 
alcohol problems (Farren & McElroy, 2010), thus this could be used to identify high risk 
clients. Stresses such as relationship and housing problems predict relapse in those with 
depression and substance misuse (Tate et al., 2008), thus coping skills to deal with these are 
important. Finally, the majority of relapses occur within two months after treatment (Tate, et 
al., 2008), so close monitoring after discharge and booster sessions are indicated.    
 
Gender differences 
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A number of gender differences are present in those with dual diagnosis. Men under-report 
mood symptoms, whilst women under-report substance misuse (Andrews, et al., 2001). Men 
are more likely to be using drugs rather than alcohol (Westreich, Guedj, Galanter, & Baird, 
1997), and have more severe problems with a greater likelihood of poly substance misuse 
(Comtois & Ries, 1995). On the other hand women are less likely to attend groups (Comtois 
& Ries, 1995). In those with depression and alcohol problems, if integrated interventions are 
not available then women respond better to a focus on depression, whereas men respond 
better to a focus on alcohol (Baker, et al., 2010). Thus different interventions may be required 
based on gender.  
 
Service level issues 
Mental health problems are common in drug and alcohol services, but are rarely documented 
(Cole & Sacks, 2008), whilst substance misuse is common but often missed in mental health 
settings (Weaver et al., 2003). Weaver et al. (2003) found that 44% of those seen by 
Community Mental Health Teams (CMHTs) had substance misuse, and 75% of those in drug 
and alcohol services had a mental health problem, but these were rarely detected. Research 
suggests that there are often few differences between dual diagnosis patients presenting to 
either mental health or addiction services (Havassy, Alvidrez, & Owen, 2004). Thus those 
with dual diagnosis can present to both mental health and addiction services. 
 
Dual diagnosis services are developing slowly in the U.K. National Health Service (NHS), 
perhaps due to no specific models being identified in the National Service Framework (Lowe 
& Abou-Saleh, 2004). The Department of Health (2002) suggests that those with dual 
diagnosis should be offered integrated care within mental health services, with specialist 
addiction support only when essential as moving between services may increase the risk of 
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drop out. The NICE guidelines for bipolar disorder similarly state that co-morbid substance 
should be treated within mental health services (NICE, 2006). 
  
The Department of Health (2002) suggests that staff in mental health settings should be given 
dual diagnosis training, indicating a training role for clinical psychologists and other dual 
diagnosis specialists. Such training has been offered to some U.K. assertive outreach teams 
with beneficial effects (Graham, 2004; Graham et al., 2006). Recent dual diagnosis service 
innovations of note include the COMPASS service in Birmingham which combines 
psychosis and substance misuse treatment (Graham et al., 2003) and the Haringey dual 
diagnosis service which aims to bring dual diagnosis insights to mental health teams, and 
help transfer between services (Lowe & Abou-Saleh, 2004). 
 
Summary of Clinical Implications 
Co-morbid substance misuse is common in depression and bipolar disorder and is associated 
with a number of negative outcomes. Thus it is important to screen those with depression and 
bipolar disorder for drug and alcohol misuse. Increased suicide risk, aggression, psychosis 
and impulsivity require close monitoring and appropriate risk assessments to be conducted. 
Those who are male, younger, unmarried, and have an anxiety or personality disorder are 
especially high risk for substance misuse and appropriate preventative interventions may be 
warranted.   
 
It may be unclear what the ‘primary’ problem is though this is of limited importance for 
therapy. Assessments are best completed during times of stable mood and no acute 
intoxication. Self-report is usually accurate if patients are stable and collateral reports may 
have little additional benefit. Care is required when using standardised measures as many 
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have not been validated for use with dual diagnosis populations. Only appropriately validated 
measures such as the ‘Chemical Use, Abuse and Dependence scale’ should be used to screen 
for substance misuse in those with mental illness. In those with substance misuse, depression 
should be screened for using specifically modified versions of questionnaires such as the 
‘Hamilton Depression Rating Scale’.   
 
Evidence is somewhat limited at present, but integrated interventions where mood symptoms 
and substance misuse are tackled together may be effective. Integrated CBT can be used with 
depression and substance misuse but there is little work relating to bipolar disorder. CBT 
appears to be especially effective if beliefs about substance misuse and self-efficacy are 
targeted, and motivational interviewing should be used as in addition to psychological 
therapy. Group interventions which use psychoeducation and peer support with a relapse 
prevention approach appear to be effective though the evidence is better for bipolar disorder 
than depression. These should include assertiveness and social skills training, and try to 
tackle beliefs about the effectiveness of self-medication. Other approaches such as MBCT 
need to be specifically adapted and researched before use with this population.  
 
Clinicians’ should emphasise harm reduction rather than total abstinence, though acute 
intoxication may interfere with therapy. Relapse is common and ongoing monitoring and care 
is required. Those with poor cognitive functioning, younger, of low socio-economic or ethnic 
minority status may have poorer outcomes so require extra intervention. More severe 
affective symptoms also lead to poorer outcomes so stabilisation of mood prior to 
intervention is warranted. Addiction severity and craving should also be assessed as they 
increase the risk of relapse. Clinicians’ should be aware of gender differences and may need 
to focus more on substance misuse in men. Finally, integrated care should be offered within 
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CMHTs where possible, though staff in all clinical settings should be trained in dual 
diagnosis.   
 
Conclusion 
This essay has explored issues relating to working with co-morbid substance misuse in those 
with depression and bipolar disorder. Conclusions are limited to an extent as some issues 
discussed here relate to dual diagnosis in general, and there is often little research on 
depression and bipolar disorder specifically, despite the high levels of co-morbidity in this 
population. Previous reviews have similarly concluded that there is insufficient work on the 
effectiveness of dual diagnosis interventions for specific mental health problems (Tiet & 
Mausbach, 2007). In addition some therapeutic techniques have not yet been adapted for dual 
diagnosis work. Research so far often suffers from methodological problems such as short 
follow-up periods and small samples (Horsfall, Cleary, Hunt, & Walter, 2009).  
 
However it is clear that substance misuse is common in depression and bipolar disorder, and 
such misuse has a number of negative effects. Co-morbid substance misuse therefore poses a 
number of challenges to clinicians, and the differences between those with and without 
substance use need to be taken into account. The necessity of integrated treatment is currently 
ambiguous and the effectiveness of a number of dual diagnosis interventions is unclear due to 
little research. Similarly dual diagnosis services in the U.K. are developing slowly and where 
such clients fit within the NHS is somewhat uncertain at present. Additional research on 
depression and bipolar disorder specifically will help better understand the clinical 
implications of dual diagnosis and assist the development of specific assessment and 
intervention techniques for this population. This will allow in turn for the development of 
more effective dual diagnosis services.  
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